Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Miton Regulatory News (PMI)

Share Price Information for Premier Miton (PMI)

Share Price is delayed by 15 minutes
Get Live Data
36.00    -1.50 (-4.00%)
Bid:
35.50
Ask:
36.50
Spread: 1.00 (2.817%)
Market Cap: £56.73m
PMI Live PriceLast checked at - London Stock Exchange

Intraday Premier Miton Share Chart

Form 8.3 - Premier Miton Group plc

24 Nov 2021 13:50

RNS Number : 4902T
Franklin Resources, Inc
24 November 2021
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Franklin Resources, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Premier Miton Group plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

23 November 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

0.02p ordinary

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

4,215,000

2.67%

(2) Cash-settled derivatives:

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

TOTAL:

4,215,000

2.67%

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

24 November 2021

Contact name:

Cathy Johnson

Telephone number*:

954-527-7580

subsshholder@franklintempleton.com

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETFLFSVLTLSFIL
Date   Source Headline
4th Jun 20267:00 amRNSHalf Year Results - Six Months Ended 31 March 2026
27th May 20265:37 pmRNSHolding(s) in Company
20th May 20261:17 pmRNSHolding(s) in Company
19th May 20265:31 pmRNSTR-1: Notification of major holdings
18th May 20264:43 pmRNSInvestor Presentation via Investor Meet Company
15th May 202612:55 pmRNSNotice of Results
24th Apr 20263:17 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSQ2 AuM update
15th Apr 20262:44 pmRNSHolding(s) in Company
7th Apr 20263:44 pmRNSHolding(s) in Company
31st Mar 20265:42 pmRNSTransfer of Initial Consideration Shares
31st Mar 20263:18 pmRNSHolding(s) in Company
31st Mar 20269:43 amRNSHolding(s) in Company
27th Mar 20262:56 pmRNSHolding(s) in Company
19th Mar 20268:15 amRNSChange of Registered Office
17th Mar 202610:28 amRNSHolding(s) in Company
4th Mar 20262:25 pmRNSDirector/PDMR Shareholding
20th Feb 20267:13 amRNSDirector/PDMR Shareholding
5th Feb 202612:00 pmRNSHolding(s) in Company
4th Feb 20262:02 pmRNSResult of Annual General Meeting
3rd Feb 20264:21 pmRNSHolding(s) in Company
26th Jan 20263:57 pmRNSHolding(s) in Company
21st Jan 20269:32 amRNSFurther re: Notice of AGM
15th Jan 20267:00 amRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ1 AuM update
13th Jan 20266:06 pmRNSPDMR/Director Dealing
29th Dec 20255:03 pmRNSPDMR/Director Dealing
29th Dec 20255:03 pmRNSPDMR/Director Dealing
22nd Dec 20255:54 pmRNSAnnual Report and Notice of AGM
22nd Dec 20255:54 pmRNSAnnual Report and Notice of AGM
5th Dec 202511:25 amRNSHolding(s) in Company
4th Dec 20257:01 amRNSChair Designate Appointment
4th Dec 20257:00 amRNSFULL YEAR RESULTS
19th Nov 20259:36 amRNSInvestor Presentation via Investor Meet Company
19th Nov 20257:00 amRNSNotification of major holdings
24th Oct 20253:38 pmRNSTR-1: Notification of Major Holdings
20th Oct 20258:20 amRNSTR-1 Notification of major holdings
14th Oct 202511:24 amRNSHolding(s) in Company
14th Oct 20259:42 amRNSHolding(s) in Company
10th Oct 20257:00 amRNSQ4 AuM update and Notice of results
8th Oct 20251:27 pmRNSHolding(s) in Company
30th Sep 20253:16 pmRNSHolding(s) in Company
29th Sep 20252:37 pmRNSHolding(s) in Company
25th Sep 20252:41 pmRNSHolding(s) in Company
24th Sep 20255:42 pmRNSHolding(s) in Company
12th Sep 20253:00 pmRNSHolding(s) in Company
10th Sep 202512:31 pmRNSHolding(s) in Company
9th Sep 20254:15 pmRNSHolding(s) in Company
4th Sep 202510:18 amRNSDirector/PDMR Shareholding
18th Aug 20254:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.